Medical Developments International Limited
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more
Medical Developments International Limited (MDDVF) - Net Assets
Latest net assets as of June 2025: $55.10 Million USD
Based on the latest financial reports, Medical Developments International Limited (MDDVF) has net assets worth $55.10 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($66.40 Million) and total liabilities ($11.29 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $55.10 Million |
| % of Total Assets | 82.99% |
| Annual Growth Rate | 9.49% |
| 5-Year Change | -19.32% |
| 10-Year Change | 189.64% |
| Growth Volatility | 28.66 |
Medical Developments International Limited - Net Assets Trend (2003–2025)
This chart illustrates how Medical Developments International Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medical Developments International Limited (2003–2025)
The table below shows the annual net assets of Medical Developments International Limited from 2003 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $55.10 Million | +20.49% |
| 2024-06-30 | $45.73 Million | -43.76% |
| 2023-06-30 | $81.31 Million | +41.92% |
| 2022-06-30 | $57.30 Million | -16.11% |
| 2021-06-30 | $68.30 Million | +57.60% |
| 2020-06-30 | $43.34 Million | -2.80% |
| 2019-06-30 | $44.59 Million | +111.91% |
| 2018-06-30 | $21.04 Million | -2.59% |
| 2017-06-30 | $21.60 Million | +13.53% |
| 2016-06-30 | $19.02 Million | +9.30% |
| 2015-06-30 | $17.41 Million | +10.00% |
| 2014-06-30 | $15.82 Million | +0.60% |
| 2013-06-30 | $15.73 Million | -2.72% |
| 2012-06-30 | $16.17 Million | +11.86% |
| 2011-06-30 | $14.46 Million | +13.71% |
| 2010-06-30 | $12.71 Million | +7.60% |
| 2009-06-30 | $11.81 Million | +0.11% |
| 2008-06-30 | $11.80 Million | +7.08% |
| 2007-06-30 | $11.02 Million | +11.64% |
| 2006-06-30 | $9.87 Million | +17.52% |
| 2005-06-30 | $8.40 Million | +0.31% |
| 2004-06-30 | $8.37 Million | +11.62% |
| 2003-06-30 | $7.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medical Developments International Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6276500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $115.01 Million | 208.71% |
| Other Comprehensive Income | $2.86 Million | 5.19% |
| Other Components | $1.00 | 0.00% |
| Total Equity | $55.10 Million | 100.00% |
Medical Developments International Limited Competitors by Market Cap
The table below lists competitors of Medical Developments International Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sai Gon Mien Trung Beer JSC
VN:SMB
|
$38.35 Million |
|
Genomics BioSci & Tech. Co.Ltd.
TWO:4195
|
$38.36 Million |
|
EBQLF
PINK:EBQLF
|
$38.37 Million |
|
C3 Metals Inc
OTCQB:CUAUF
|
$38.37 Million |
|
Atrium Real Estate Investment Trust
KLSE:5130
|
$38.35 Million |
|
Ideal Bike
TWO:8933
|
$38.34 Million |
|
Wooree Bio Co.Ltd
KQ:082850
|
$38.34 Million |
|
REDELFI SPA
F:B0Z
|
$38.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medical Developments International Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 45,734,000 to 55,104,000, a change of 9,370,000 (20.5%).
- Net income of 94,000 contributed positively to equity growth.
- Share repurchases of 1,040,000 reduced equity.
- New share issuances of 10,014,000 increased equity.
- Other comprehensive income decreased equity by 2,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $94.00K | +0.17% |
| Share Repurchases | $1.04 Million | -1.89% |
| Share Issuances | $10.01 Million | +18.17% |
| Other Comprehensive Income | $-2.00K | -0.0% |
| Other Changes | $304.00K | +0.55% |
| Total Change | $- | 20.49% |
Book Value vs Market Value Analysis
This analysis compares Medical Developments International Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.03x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.92x to 1.03x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-06-30 | $0.13 | $0.51 | x |
| 2004-06-30 | $0.18 | $0.51 | x |
| 2005-06-30 | $0.15 | $0.51 | x |
| 2006-06-30 | $0.17 | $0.51 | x |
| 2007-06-30 | $0.19 | $0.51 | x |
| 2008-06-30 | $0.20 | $0.51 | x |
| 2009-06-30 | $0.21 | $0.51 | x |
| 2010-06-30 | $0.24 | $0.51 | x |
| 2011-06-30 | $0.28 | $0.51 | x |
| 2012-06-30 | $0.30 | $0.51 | x |
| 2013-06-30 | $0.28 | $0.51 | x |
| 2014-06-30 | $0.27 | $0.51 | x |
| 2015-06-30 | $0.30 | $0.51 | x |
| 2016-06-30 | $0.33 | $0.51 | x |
| 2017-06-30 | $0.37 | $0.51 | x |
| 2018-06-30 | $0.36 | $0.51 | x |
| 2019-06-30 | $0.68 | $0.51 | x |
| 2020-06-30 | $0.65 | $0.51 | x |
| 2021-06-30 | $0.98 | $0.51 | x |
| 2022-06-30 | $0.79 | $0.51 | x |
| 2023-06-30 | $0.96 | $0.51 | x |
| 2024-06-30 | $0.53 | $0.51 | x |
| 2025-06-30 | $0.49 | $0.51 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medical Developments International Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.24%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 1.20x
- Recent ROE (0.17%) is above the historical average (-0.43%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 5.74% | 15.78% | 0.24x | 1.49x | $-356.40K |
| 2005 | 2.00% | 3.11% | 0.47x | 1.38x | $-672.00K |
| 2006 | 8.07% | 12.07% | 0.53x | 1.27x | $-190.20K |
| 2007 | 10.95% | 16.32% | 0.61x | 1.10x | $104.90K |
| 2008 | 7.55% | 9.66% | 0.70x | 1.12x | $-289.10K |
| 2009 | 6.86% | 9.28% | 0.65x | 1.13x | $-371.40K |
| 2010 | 6.91% | 10.60% | 0.58x | 1.12x | $-392.20K |
| 2011 | 12.06% | 17.08% | 0.61x | 1.16x | $297.50K |
| 2012 | 16.72% | 23.90% | 0.59x | 1.18x | $1.09 Million |
| 2013 | 14.68% | 19.68% | 0.58x | 1.29x | $736.10K |
| 2014 | 5.53% | 9.34% | 0.42x | 1.43x | $-707.40K |
| 2015 | 8.78% | 13.17% | 0.50x | 1.32x | $-211.70K |
| 2016 | 8.25% | 10.14% | 0.38x | 2.17x | $-333.50K |
| 2017 | 8.43% | 9.92% | 0.44x | 1.93x | $-340.00K |
| 2018 | 1.15% | 1.39% | 0.35x | 2.35x | $-1.86 Million |
| 2019 | 2.33% | 4.97% | 0.25x | 1.90x | $-3.42 Million |
| 2020 | 0.87% | 1.68% | 0.24x | 2.19x | $-3.95 Million |
| 2021 | -18.40% | -49.72% | 0.25x | 1.47x | $-19.40 Million |
| 2022 | -21.65% | -56.54% | 0.22x | 1.77x | $-18.14 Million |
| 2023 | -6.90% | -17.35% | 0.30x | 1.35x | $-13.74 Million |
| 2024 | -89.63% | -123.66% | 0.56x | 1.29x | $-45.57 Million |
| 2025 | 0.17% | 0.24% | 0.59x | 1.20x | $-5.42 Million |
Industry Comparison
This section compares Medical Developments International Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medical Developments International Limited (MDDVF) | $55.10 Million | 5.74% | 0.20x | $38.35 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |